These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3998198)

  • 1. Plasma concentration-response relationships of two formulations of propranolol.
    DeLeve LD; Endrenyi L; Leenen FH
    J Clin Pharmacol; 1985 Apr; 25(3):182-6. PubMed ID: 3998198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor binding of propranolol is the missing link between plasma concentration kinetics and the effect-time course in man.
    Wellstein A; Palm D; Pitschner HF; Belz GG
    Eur J Clin Pharmacol; 1985; 29(2):131-47. PubMed ID: 3000793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of drug concentration measurements in studies of the therapeutic response to propranolol.
    Chidsey C; Pine M; Favrot L; Smith S; Leonetti G; Morselli P; Zanchetti A
    Postgrad Med J; 1976; 52 Suppl 4():26-32. PubMed ID: 967771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of plasma propranolol concentration with therapeutic response in patients with angina pectoris.
    Pine M; Favrot L; Smith S; McDonald K; Chidsey CA
    Circulation; 1975 Nov; 52(5):886-93. PubMed ID: 1175271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol dosage, plasma concentration, and beta blockade.
    Mullane JF; Kaufman J; Dvornik D; Coelho J
    Clin Pharmacol Ther; 1982 Dec; 32(6):692-700. PubMed ID: 7140135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta blockade by oral propranolol and labetalol.
    Cubeddu LX; Carr ME; Fuenmayor NJ
    Clin Pharmacol Ther; 1985 Mar; 37(3):277-83. PubMed ID: 2857602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations and the time-course of beta blockade due to propranolol.
    McDevitt DG; Shand DG
    Clin Pharmacol Ther; 1975 Dec; 18(6):708-13. PubMed ID: 1169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol in experimentally induced stress.
    Taylor EA; Harrison J; Turner P
    Br J Psychiatry; 1981 Dec; 139():545-9. PubMed ID: 7037098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.
    Parratt JR
    Br J Pharmacol; 1974 May; 51(1):5-13. PubMed ID: 4155336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflex.
    Belz GG; Essig J; Kleinbloesem CH; Hoogkamer JF; Wiegand UW; Wellstein A
    Br J Clin Pharmacol; 1988 Nov; 26(5):547-56. PubMed ID: 2974715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of beta blockade with propranolol.
    Hager WD; Pieniaszek HJ; Perrier D; Mayersohn M; Goldberger V
    Clin Pharmacol Ther; 1981 Sep; 30(3):283-90. PubMed ID: 6115730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction between halofenate and propranolol.
    Huffman DH; Azarnoff DL; Shoeman DW; Dujovne CA
    Clin Pharmacol Ther; 1976 Jun; 19(6):807-12. PubMed ID: 773588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic studies of beta adrenergic antagonism induced in man by propranolol and practolol.
    Bodem G; Brammell HL; Weil JV; Chidsey CA
    J Clin Invest; 1973 Apr; 52(4):747-54. PubMed ID: 4144332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics of propranolol on left ventricular function: assessment by Doppler echocardiography.
    Clifton GD; Pennell AT; Harrison MR
    Clin Pharmacol Ther; 1990 Oct; 48(4):431-8. PubMed ID: 2225703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time couse of the blockade effect of propranolol on sinus node and atrioventricular node.
    Boudoulas H; Dervenagas S; Lewis RP; Kates RE; Dalamangas G
    J Clin Pharmacol; 1979; 19(2-3):95-9. PubMed ID: 422743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between plasma propranolol concentration and dose in young, healthy volunteers.
    Dey M; Brisson J; Davis G; Enever R; Pray K; Zaim B; Dvornik D
    Biopharm Drug Dispos; 1986; 7(2):103-11. PubMed ID: 3708118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
    Coltart DJ; Shand DG
    Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.